Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
PAVM PAVmed Inc
- Stocks
- Healthcare
- NASDAQ: PAVM
Price (delayed)
$0.649
Market cap
$11.43M
P/E Ratio
0.1
Dividend/share
N/A
EPS
$6.52
Enterprise value
$17.97M
PAVmed Inc. is a highly differentiated, multiproduct medical device company employing a unique business model designed to advance innovative products to commercialization much more rapidly and with significantly less capital
Highlights
The EPS has soared by 172% year-on-year and by 98% since the previous quarter
The equity has surged by 165% year-on-year
PAVM's quick ratio is down by 40% year-on-year
PAVmed's revenue has decreased by 34% YoY and by 33% from the previous quarter
Key stats
What are the main financial stats of PAVM
Market
Valuations
Earnings
Shares outstanding
17.62M
Market cap
$11.43M
Enterprise value
$17.97M
Price to earnings (P/E)
0.1
Price to book (P/B)
0.24
Price to sales (P/S)
4.52
EV/EBIT
0.24
EV/EBITDA
0.24
EV/Sales
9.02
Revenue
$1.99M
Gross profit
-$1.14M
Operating income
-$35.9M
Net income
$73.97M
EBIT
$74.01M
EBITDA
$74.66M
Free cash flow
-$22.05M
Per share
Balance sheet
Liquidity
EPS
$6.52
EPS diluted
$0.3
Free cash flow per share
-$1.59
Book value per share
$2.68
Revenue per share
$0.14
TBVPS
$3.81
Total assets
$52.82M
Total liabilities
$11.89M
Debt
$9.24M
Equity
$44.99M
Working capital
-$6.14M
Debt to equity
0.21
Current ratio
0.37
Quick ratio
0.28
Net debt/EBITDA
0.09
Margins
Efficiency
Dividend
EBITDA margin
3,746.3%
Gross margin
-57.1%
Net margin
3,711.5%
Operating margin
-1,801.1%
Return on assets
188.9%
Return on equity
N/A
Return on invested capital
263.7%
Return on capital employed
171.9%
Return on sales
3,713.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PAVM stock price
How has the PAVmed stock price performed over time
Intraday
3.03%
1 week
-4.82%
1 month
-4.56%
1 year
-65.48%
YTD
3.43%
QTD
-10.04%
Financial performance
How have PAVmed's revenue and profit performed over time
Revenue
$1.99M
Gross profit
-$1.14M
Operating income
-$35.9M
Net income
$73.97M
Gross margin
-57.1%
Net margin
3,711.5%
The net margin has soared by 179% from the previous quarter
The net income has surged by 86% since the previous quarter
PAVM's gross profit has surged by 70% year-on-year and by 38% since the previous quarter
PAVM's gross margin has surged by 55% year-on-year and by 7% since the previous quarter
Price vs fundamentals
How does PAVM's price correlate with its fundamentals
Growth
What is PAVmed's growth rate over time
Valuation
What is PAVmed stock price valuation
P/E
0.1
P/B
0.24
P/S
4.52
EV/EBIT
0.24
EV/EBITDA
0.24
EV/Sales
9.02
The EPS has soared by 172% year-on-year and by 98% since the previous quarter
The equity has surged by 165% year-on-year
The stock's price to sales (P/S) is 51% more than its last 4 quarters average of 3.0
PAVmed's revenue has decreased by 34% YoY and by 33% from the previous quarter
Efficiency
How efficient is PAVmed business performance
The ROS has soared by 179% since the previous quarter
The company's return on invested capital has surged by 135% YoY and by 13% QoQ
PAVM's return on assets has surged by 104% since the previous quarter
Dividends
What is PAVM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PAVM.
Financial health
How did PAVmed financials performed over time
The total liabilities has dropped by 79% year-on-year and by 68% since the previous quarter
The total assets has soared by 72% from the previous quarter and by 42% YoY
The debt is 79% less than the equity
The equity has surged by 165% year-on-year
PAVM's debt to equity has surged by 129% year-on-year and by 102% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.